Dr. Farshchian of the Center for Regenerative Medicine, Keynote Speaker at the Academy of Regenerative Practices
Dr. Farshchian headlines as the keynote speaker for the Academy of Regenerative Practices, discussing cutting-edge therapies for Neurological Diseases.
MIAMI, March 9, 2018 (Newswire.com) - The Academy of Regenerative Practices is a network of physicians and scientists dedicated to the health and well being of patients through the use of regenerative therapies. We are committed to bringing cutting-edge stem cell and regenerative technology to clinical practices. Our goal is to educate medical providers on the most current cellular techniques and indications so that patients may benefit from a more natural and less invasive process.
The ARP is designed for the education of medical practitioners in the latest cellular medicine techniques and therapies. The ARP provides a forum for multiple disciplines to integrate and learn the most advanced regenerative clinical applications.
The results authenticate the effectiveness of the administration of the intranasal live cells in an individual diagnosed with Alzheimer's disease.
Vidya Maharajh, MPH, CRA, CSSGB, CDC research expert
Focused sessions on hot topics in stem cell research include stem cell reprogramming and differentiation, hematopoietic stem cells, stem cells in cancer, stem cells in vision, stem cell engineering and stem cells as a therapeutic resource, including clinical trials. The latest international research consisted of 12 spotlight talks and poster sessions featuring the most recent research findings from around the world, including Dr. Farshchian, who has been working with regenerative medicine for over 20 years.
Dr. Farshchian presented a case of an 83-year-old patient with Alzheimer’s who responded to an intranasal treatment of live cell therapy. “The results authenticate the effectiveness of the administration of the intranasal live cells in an individual diagnosed with Alzheimer’s disease,” explained Vidya Maharajh, MPH, CRA, CSSGB, a CDC research expert and co-writing a study with Dr. Farshchian.
As part of the objective measurement of the effectiveness of the therapy, Farshchian used the standard mini-mental status exam. As part of the exam review, the patient is asked to draw a clock. Farshchian explained how the patient was able to go from a disorganized thought to a more refined ability to remember the clock concept at hand. According to Mr. Roman Garcia, PT and Dr. Farshchian's assistant; “maintaining objectivity in the pre- and post-examination protocol is vital for outcome evaluation.”
“Of the estimated 5.5 million Americans living with Alzheimer’s dementia in 2017, an estimated 5.3 million are age 65 and older, and approximately 200,000 individuals are under age 65 and have younger-onset Alzheimer’s. One in 10 people age 65 and older (10 percent) has Alzheimer’s dementia,” according to Alzheimer's.org.
Dr. Farshchian, the medical director for The Center for Regenerative Medicine, which he founded in 2000 to pursue a pioneering regimen in the treatment of Arthritis and neurodegenerative diseases, is also a medical doctor, medical author and humanitarian in Miami Florida. In 2005 he performed the first autologous live cell transplantation into a knee in the U.S.A. Dr. Farshchian said, “I am very encouraged by the intranasal Live cell technique to treat Alzheimer’s, it is promising.” (http://www.arthritisusa.net/Optic-Regeneration). Alimorad Farshchian MD. He is the director of The Center for Regenerative Medicine, which he founded in 2000 to pursue pioneering regimens in the treatment of arthritis and neurodegenerative diseases. In 2005 he performed the first autologous live cell transplantation into an arthritic knee in the U.S.A. For the 2012 London Olympics and 2016 Rio Olympics, Farshchian served as consulting Orthopedic Regenerative Medicine physician for the Team USA track-and-field team.
Earlier today, the spokesman for Dr. Farshchian, Mr. Bernardo Lessa-Bastos said, “We are very proud to be contributing to our medical community by attending and sharing our experiences and extensive knowledge of Mononuclear cells and their use in modern medicine today.”
For further information, please contact The Center for Regenerative Medicine Representatives:
Bernard Lessa-Bastos
305-891-4686
Source: The Center for Regenerative Medicine
Related Media
